Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma

Leukemia and Lymphoma

Volumn 48, Issue 2, 2007, Pages 367-373

  Merli, F ^a   Bertini, M ^b   Luminari, S ^c   Mozzana, R ^d   Botto, B ^b   Liberati, A M ^e   Baldini, L ^f   Cabras, G ^g   Di Vito, F ^h   Orsucci, L ^b   Naglieri, E ⁱ   Polimeno, G ^j   Marcheselli, L ^c   Pennese, E ^k   Vitolo, U ^b   Federico, M ^c   Gallo, E ^b  

^a Unita Operativa di Reumatologia   (Italy)

^b Struttura Complessa di Neurologia   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d Azienda Ospedaliera S Antonio Abate di Gallarate   (Italy)

^e POLICLINICO MONTELUCE   (Italy)

^f Centro G Marcora   (Italy)

^g Ospedale Oncologico A Businco   (Italy)

^h Ospedale Regionale   (Italy)

ⁱ NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^j MIULLI GENERAL HOSPITAL   (Italy)

^k SPIRITO SANTO HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; KETOCONAZOLE; PREDNISONE; VINBLASTINE; ANTINEOPLASTIC AGENT; CEOP PROTOCOL 1; P VEBEC PROTOCOL; P-VEBEC PROTOCOL; UNCLASSIFIED DRUG; VINCRISTINE;

AGED; ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; GERIATRIC PATIENT; HEART DISEASE; HUMAN; INFECTION; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; PHASE 3 CLINICAL TRIAL; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; EPIRUBICIN; ETOPOSIDE; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; PREDNISONE; QUALITY OF LIFE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VINBLASTINE; VINCRISTINE;

EID: 34247843100     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190601078100     Document Type: Article

References (24)

1. Vose, J. M., Armitage, J. O., Weisenburger, D. D., Bierman, P. J., Sorensen, S. and Hutchins, M. (1988) The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. J Clin Oncol, 6, pp. 1838-1844.
2. O'Reilly, S. E., Klimo, P. and Connors, J. M. (1991) Low-dose ACOP-B and VABE: Weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma. J Clin Oncol, 9, pp. 741-747.
3. Tirelli, U., Zagonel, V., Errante, D., Serraino, D., Talamini, R. and De Cicco, M. (1992) A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma. J Clin Oncol, 10, pp. 228-236.
4. Martelli, M., Guglielmi, C., Coluzzi, S., Avvisati, G., Amadori, S. and Giovannini, M. (1993) P-VABEC: A prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma. J Clin Oncol, 11, pp. 2362-2369.
5. Zinzani, P. L., Storti, S., Zaccaria, A., Moretti, L., Magagnoli, M. and Pavone, E. (1999) Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients. Blood, 94, pp. 33-38.
6. Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M. and Mize, E. M. (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med, 328, pp. 1002-1006.
7. Doorduijn, J. K., van der Holt, B., van Imhoff, G. W., van der Hem, K. G., Kramer, M. H. and van Oers, M. H. (2003) CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. J Clin Oncol, 21, pp. 3041-3050.
8. Sonneveld, P., de Ridder, M., van der Lelie, H., Nieuwenhuis, K., Schouten, H. and Mulder, A. (1995) Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy. J Clin Oncol, 13, pp. 2530-2539.
9. Meyer, R. M., Browman, G. P., Samosh, M. L., Benger, A. M., Bryant-Lukosius, D. and Wilson, W. E. (1995) Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma. J Clin Oncol, 13, pp. 2386-2393.
10. Osby, E., Hagberg, H., Kvaloy, S., Teerenhovi, L., Anderson, H. and Cavallin-Stahl, E. (2003) CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: Results of a Nordic Lymphoma Group randomized trial. Blood, 101, pp. 3840-3848.
11. Bertini, M., Freilone, R., Vitolo, U., Botto, B., Ciotti, R. and Cinieri, S. (1996) The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: Feasibility and efficacy of an intensive multidrug regimen. Leuk Lymphoma, 22, pp. 483-493.
12. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K. and Cleary, M. L. (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84, pp. 1361-1392.
13. A predictive model for aggressive non-Hodgkin's lymphoma (1993) The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med, 329, pp. 987-994.
14. Hryniuk, W. and Bush, H. (1984) The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol, 2, pp. 1281-1288.
15. Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A. and Duez, N. J. (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85, pp. 365-376.
16. Esteve, J., Benhamou, E., Croasdale, M. and Raymond, L. (1990) Relative survival and the estimation of net survival: Elements for further discussion. Stat Med, 9, pp. 529-538.
17. Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H. and Bouabdallah, R. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med, 346, pp. 235-242.
18. Yellen, S. B., Cella, D. F. and Leslie, W. T. (1994) Age and clinical decision making in oncology patients. J Natl Cancer Inst, 86, pp. 1766-1770.
19. Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients (1997) The Non-Hodgkin's Lymphoma Classification Project. Ann Oncol, 8, pp. 973-978.
20. Merli, F., Bertini, M., Luminari, S., Mozzana, R., Berte, R. and Trottini, M. (2004) Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi. Haematologica, 89, pp. 973-978.
21. Feugier, P., Van Hoof, A., Sebban, C., Solal-Celigny, P., Bouabdallah, R. and Ferme, C. (2005) Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol, 23, pp. 4117-4126.
22. Pfreundschuh, M., Trumper, L., Kloess, M., Schmits, R., Feller, A. C. and Rube, C. (2004) Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: Results of the NHL-B2 trial of the DSHNHL. Blood, 104, pp. 634-641.
23. Sehn, L. H., Donaldson, J., Chhanabhai, M., Fitzgerald, C., Gill, K. and Klasa, R. (2005) Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol, 23, pp. 5027-5033.
24. Monfardini, S. and Balducci, L. (1999) A comprehensive geriatric assessment (CGA) is necessary for the study and the management of cancer in the elderly. Eur J Cancer, 35, pp. 1771-1772.